mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.4 |